Institute of Personalized Medicine - PUMA IPM

Pharmacogenomics aims at understanding how variations in the human genome affect the response to medications.

Our researchers are working to generate new knowledge, and to develop tools and algorithms that can help in personalizing medicine utilizing a patient’s genetic profile and other factors to achieve maximum therapeutic benefit with minimum toxicity.

News

Pamala Jacobson received the Sara Evans Faculty Woman Scholar/ Leader Award from the University of Minnesota Women’s Center, Office for Equity and Diversity and was honored at their Celebrating Changemakers Awards event on October 11, 2018.

This session highlighted the social and cultural challenges associated with providing care to local Native American tribes in Minnesota, who face larger health disparities than other populations.

David S

David Stenehjem works in the rapidly growing field of outcomes research, which guides his research on midostaurin in FLT3-mutated acute myeloid leukemia.

Sam CallistoSamuel is a PhD Candidate in the Experimental and Clinical Pharmacology department. During his time in the program Samuel has pursued various avenues of research related to precision medicine in neuropharmacology with a focus on anti-seizure drugs.

Weekly Genomics Scan

This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.

Precision Medicine Seminar Series

"Precision Medicine in Mental Health: Challenges and Opportunities for Pharmacogenomics" 

Presented by Jeffrey R. Bishop, PharmD, MS, BCPP
Associate Professor of Experimental & Clinical Pharmacology, University of Minnesota

 
Friday, April 5
2 PM - 3 PM
5-125 Moos Tower (TC); 302 Heller Hall (Duluth via ITV)
 
Dr. Jeff Bishop is associate professor of pharmacy and psychiatry at the University of Minnesota. In this role, he conducts psychopharmacology and pharmacogenomics research with a focus on examining genetic relationships with symptom improvement, side effects, and cognitive effects of medications. He is a Board Certified Psychiatric Pharmacist, providing clinical and didactic education to the pharmacy and medical trainees. Dr. Bishop earned a degree in biology at Luther College and went on to complete his Doctor of Pharmacy degree at the University of Iowa. Subsequently, he completed a fellowship in clinical psychopharmacology and pharmacogenetics at the University of Iowa College of Pharmacy as well as a master’s degree in Clinical Investigation through the University of Iowa College of Medicine. His research work has been supported through local, foundation, and NIH funding mechanisms.
 
Seminar Poster
 
This event is free and open to the public. Light refreshments will be served.

Pharmacogenomics
Conference

Genomic Testing to Individualize Drug Therapy

The 2018 Pharmacogenomics Conference on June 22 was at capacity with over 310 registrants in attendance.  Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas.  Read about the event here

University Precision Medicine Initiatives

Bringing together scientists, healthcare providers, patients and payers in the area of precision medicine to promote research, education and the use of precision medicine and health to improve human health.

Transforming health and advancing equity by generating precision treatments of disease to advance health outcomes for all Minnesotans.